SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001439222-23-000069
Filing Date
2023-06-15
Accepted
2023-06-15 16:13:44
Documents
3
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1686860015.html 3  
1 FORM 3 wk-form3_1686860015.xml 3 1661
2 EX-24.1 exhibit241-poaxowen.htm EX-24.1 4819
3 GRAPHIC exhibit241-poaxowen001.jpg GRAPHIC 306395
  Complete submission text file 0001439222-23-000069.txt   430009
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address
Owen Catherine E. (Reporting) CIK: 0001816838 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 231017493